Stocks to Watch: SVRN, Inovio, Intel

AI Market Summary

Inovio's FDA accelerated approval drove a near-tripling after hours, a strong idiosyncratic biotech catalyst. SVRN's delisting warning and Intel's modest after-hours decline offset the positive tone. The news is company-specific rather than macro, so broad market impact is limited; expect stock-level volatility with minimal spillover to indices.

Impact level

● Medium

Affected assets

NCSKINTC2USD/USDT-8.04%

AI Insight · NCSKINTC2USD/USDTAI Insight

● Neutral

Trade now

⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.

Inovio shares nearly quadrupled to $2.21 after hours as its new drug won FDA accelerated approval. SVRN dropped 8% on a delisting warning, and Intel fell another 1.5% after hours.

Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.

Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.